Role of inflammation in diabetic complications

被引:196
作者
Navarro, JF
Mora, C
机构
[1] Hosp Univ Nvestra Senora Candelaria, Serv Nefrol, Santa Cruz de Tenerife, Spain
[2] Hosp Univ Nvestra Senora Candelaria, Inst Canario Invest Biomed, Santa Cruz de Tenerife, Spain
[3] CSIC, Ctr Invest Biol, Madrid, Spain
关键词
cytokines; diabetes; diabetic nephropathy; inflammation; pentoxifylline; tumor necrosis factor-alpha;
D O I
10.1093/ndt/gfi155
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:2601 / 2604
页数:5
相关论文
共 34 条
[31]   End-stage renal failure in type 2 diabetes:: A medical catastrophe of worldwide dimensions [J].
Ritz, E ;
Rychlík, I ;
Locatelli, F ;
Halimi, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05) :795-808
[32]   TUMOR NECROSIS FACTOR AND INTERLEUKIN 1-ALPHA-INCREASE VASCULAR ENDOTHELIAL PERMEABILITY [J].
ROYALL, JA ;
BERKOW, RL ;
BECKMAN, JS ;
CUNNINGHAM, MK ;
MATALON, S ;
FREEMAN, BA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (06) :L399-L410
[33]  
Satoh Jo, 2003, Exp Diabesity Res, V4, P65, DOI 10.1155/EDR.2003.65
[34]   Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes [J].
Utimura, R ;
Fujihara, CK ;
Mattar, AL ;
Malheiros, DMAC ;
Noronha, ID ;
Zatz, R .
KIDNEY INTERNATIONAL, 2003, 63 (01) :209-216